Accretive Health (AH) Tops Q4 EPS by 1c; Issues FY12 EPS, Revs Outlook
Tweet
Share
E-mailGet Alerts AH Hot Sheet
Join SI Premium – FREE
Accretive Health (NYSE: AH) reported Q4 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $260.1 million versus the consensus estimate of $254.27 million.
Sees FY12 revs of $1.09 billion to $1.12 billion and EPS of 61 to 65 cents, versus views calling for revs of $1.12 billion and EPS of 69 cents.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Sees FY12 revs of $1.09 billion to $1.12 billion and EPS of 61 to 65 cents, versus views calling for revs of $1.12 billion and EPS of 69 cents.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Live Ventures (LIVE) Reports Q3 Loss of $0.34
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
